Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis

NCT00004938 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT00004938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Phase 2
Overall status
Completed
Start date
August 31, 1996
Completion date
August 31, 1996
Enrollment
30
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sporotrichosis